Every 10-Q that Blend Labs Inc (BLND) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BLND and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BLND filings page.
Blend Labs, Inc. reported for the three months ended June 30, 2026 total revenue of $33.8 million, up from $31.6 million a year earlier, with six‑month revenue of $64.7 million versus $58.5 million. Loss from operations for the quarter narrowed to $1.6 million from $4.8 million, and net loss was $1.5 million versus $6.8 million. Net loss attributable to common stockholders was $6.4 million for the quarter and $19.2 million for the six months, with basic and diluted net loss per share of $0.03 and $0.08, respectively, for the current quarter and year‑to‑date.
At June 30, 2026, total assets were $143.6 million, including cash and cash equivalents of $23.3 million, marketable securities of $21.6 million, and restricted cash of $1.9 million. Stockholders’ equity reflected a deficit of $74.4 million, alongside $169.2 million of Series A redeemable convertible preferred stock classified in mezzanine equity, with a maximum redemption value of $300.0 million. Net cash provided by operating activities from continuing operations was $16.2 million for the six months. The company completed the sale of substantially all title business assets on March 1, 2026, now reporting a single segment, and disclosed remaining performance obligations of $168.5 million.
Blend Labs, Inc. reports higher Q1 2026 revenue but continues to post losses as it reshapes its business. Revenue from continuing operations rose to $30.8 million from $26.8 million a year earlier, driven by software platform revenue of $28.0 million and professional services of $2.9 million.
The company recorded a loss from continuing operations of $5.5 million and a net loss of $8.0 million, both improved versus Q1 2025. Discontinued title operations added a $2.6 million loss, including a $2.5 million loss on the March 1, 2026 sale of title assets.
Blend ended March 31, 2026 with $37.4 million in cash and cash equivalents and $21.6 million in marketable securities, while operating activities from continuing operations generated $8.5 million of cash. A substantial share repurchase of 10.0 million Class A shares for $16.6 million helped reduce common shares outstanding, but stockholders’ equity stood at a negative $55.9 million, alongside $164.2 million of Series A redeemable convertible preferred stock classified in mezzanine equity.
Blend Labs (BLND) reported Q3 results showing steady revenue and a swing to GAAP profitability. Total revenue was $32.860 million versus $33.104 million a year ago, as stronger Consumer Banking Suite offset softer Mortgage Suite. Gross profit was essentially flat, while operating loss narrowed to $4.911 million from $11.283 million on lower R&D and sales and marketing spend.
GAAP net income was $12.532 million, aided by $16.6 million of gains from a non‑marketable equity investment; net income attributable to common stockholders was $7.974 million, or $0.03 basic ($0.02 diluted) per share. Cash and cash equivalents were $55.021 million and marketable securities were $22.234 million. Deferred revenue rose to $25.325 million. Remaining performance obligations totaled $189.0 million, with approximately half expected to be recognized over the next 12 months. The Title business is classified as discontinued operations. As of October 31, 2025, Class A shares outstanding were 256,119,535 and Class B shares were 3,627,385.
Blend Labs (BLND) Q2-25 10-Q highlights:
- Revenue rose 9.9% YoY to $31.5 m; software platform revenue grew 11.0% to $29.4 m, while services slipped 4.0% to $2.1 m.
- Gross margin expanded to 74.0% (vs. 70.9%), lifting gross profit to $23.3 m (+14.6%).
- Cost discipline: R&D -43%, Sales & Marketing -23%, offset by G&A +20%; total opex fell 16% to $27.9 m.
- Operating loss narrowed sharply to $(4.6) m from $(13.1) m; net loss attributable to common holders improved to $(11.0) m, or $(0.04)/share, vs. $(23.6) m, $(0.09).
- Six-month view: revenue +11% to $58.3 m; net loss cut 61% to $(25.7) m.
- Cash & equivalents $36.5 m; marketable securities $51.8 m, giving liquidity of $88.3 m. Operating cash flow turned positive at +$14.8 m (vs. -$6.3 m LY).
- Balance sheet: stockholders’ equity improves to $(22.6) m from $(56.4) m, helped by reclassifying the Title365 non-controlling interest to equity and lower deficit. Deferred revenue jumped to $32.7 m (from $19.2 m), signaling larger future delivery obligations.
- Capital structure: 260.1 m shares outstanding (Class A/B); 150k Series A preferred now carries $150.2 m redemption value, with $4.4 m quarterly accretion; warrant for 11.1 m Class A shares unexercised.
- Strategic actions: Title business classified as discontinued; Q2 discontinued loss $(3.0) m. Minority buy-out ended put option, removing $52 m mezzanine liability.
Outlook: Management stresses cost control and liquidity; no formal guidance provided.